BNP Paribas Financial Markets
PMVP icon

BNP Paribas Financial Markets’s PMV Pharmaceuticals PMVP Stock Holding History

BNP Paribas Financial Markets’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$668 Buy
539
+21
+4% +$27 ﹤0.01% 5512
2025
Q4 		$648 Sell
518
-27
-5% -$36 ﹤0.01% 5451
2025
Q3 		$763 Hold
545
– – ﹤0.01% 5261
2025
Q2 		$578 Buy
545
+1
+0.2% +$1 ﹤0.01% 5211
2025
Q1 		$593 Sell
544
-219
-29% -$297 ﹤0.01% 5125
2024
Q4 		$1.15K Buy
+763
New +$1.21K ﹤0.01% 5068

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BNP Paribas Financial Markets's PMVP Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its PMV Pharmaceuticals (PMVP) stake by 4.1% in Q1 2026, buying an estimated $27 and bringing the position to 539 shares worth $668. The position accounts for ﹤0.01% of the portfolio, ranked #5512.

BNP Paribas Financial Markets first reported a position in PMVP in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.15K in Q4 2024. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • BNP Paribas Financial Markets held 539 shares of PMV Pharmaceuticals worth $668 as of Q1 2026.
  • BNP Paribas Financial Markets bought 21 PMV Pharmaceuticals shares in Q1 2026, an estimated $27.
  • PMV Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5512 holding.
  • BNP Paribas Financial Markets first reported a position in PMV Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's PMV Pharmaceuticals position peaked at $1.15K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.